Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_provenance.
- NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_assertion description "[The CD44v8-10- to -standard CD44 ratio was measured in the tissue (40 urothelial cancer specimens and corresponding normal urinary tissue) and spontaneously voided urine samples of 150 patients with urothelial cancer and 50 with benign urological disease by reverse transcriptase-polymerase chain reaction using the set of primers capable of amplifying all CD44 splice variant isoforms.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_provenance.
- NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_assertion evidence source_evidence_literature NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_provenance.
- NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_assertion SIO_000772 11832714 NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_provenance.
- NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_assertion wasDerivedFrom befree-20150227 NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_provenance.
- NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_assertion wasGeneratedBy ECO_0000203 NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_provenance.
- befree-20150227 importedOn "2015-02-27" NP295987.RAxc8RxXh4hg2mxX34pZecS7B-l606ZyGTkAHtCpT9Bdc130_provenance.